secwatch.observer — SEC 8-K summary
======================================

Issuer:     Privia Health Group, Inc. (PRVA)
CIK:        0001759655
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001759655-23-000023
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Privia Health Q4 revenue $364.4M (+32% YoY); net income $17.8M vs loss; FY2022 above guidance
--------------------------------------------------------------------------------

- Q4 revenue $364.4M (+32.4% YoY); operating income $2.2M vs loss $19.3M.
- Q4 net income $17.8M ($0.14 diluted EPS) vs net loss $12.0M ($0.11 loss) YoY.
- Non-GAAP adjusted net income $16.1M ($0.13 diluted), up 130% YoY.
- FY2022 results at or above high end of guidance; Practice Collections growth 49.1%.
- New market entries in CT, DE, NC, OH; three new ACOs; 2023 capitated lives +38% to 40,600.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759655/000175965523000023/0001759655-23-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759655/000175965523000023/prva-20230228.htm
  HTML page:      https://secwatch.observer/filing/0001759655-23-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer